Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan.
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis.
Promoting Remyelination in Multiple Sclerosis-Recent Advances.
The stress-buffering effects of hope on changes in adjustment to caregiving in multiple sclerosis.
Multiple sclerosis: Disease activity is reduced in CIS after BCG vaccination.
The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination During Proteasomal Degradation.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Onion-shaped white matter disease?
Neuromyelitis optica-like pathology is dependent on Type I interferon response.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
Decreased serum vitamin D levels in Japanese patients with multiple sclerosis.
Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.
An unusually dry story.
[Acute transverse myelitis].
[MELATONIN TREATMENT OF AUTOIMMUNE AND ALLERGIC PATHOLOGY].
Pages
« first
‹ previous
…
494
495
496
497
498
499
500
501
502
…
next ›
last »